Results 301 to 310 of about 1,472,301 (348)
Some of the next articles are maybe not open access.
Hospital Practice, 1987
A doubling in tumor size increases metastases 10-fold and reduces surgical curability drastically. Early diagnosis, abetted by CT and ultrasound scanning, is critical.
J E, Rotolo, W M, O'Brien, J H, Lynch
openaire +2 more sources
A doubling in tumor size increases metastases 10-fold and reduces surgical curability drastically. Early diagnosis, abetted by CT and ultrasound scanning, is critical.
J E, Rotolo, W M, O'Brien, J H, Lynch
openaire +2 more sources
Current Opinion in Oncology, 2001
Several renal cell carcinoma (RCC) prognostic factors show promise, including K1-67, p53/mdm-2, and vascular endothelial growth factor. The combination of increased incidence of RCC and diagnosis during earlier stages has generated interest in local therapeutic options.
P A, Godley, M, Taylor
openaire +2 more sources
Several renal cell carcinoma (RCC) prognostic factors show promise, including K1-67, p53/mdm-2, and vascular endothelial growth factor. The combination of increased incidence of RCC and diagnosis during earlier stages has generated interest in local therapeutic options.
P A, Godley, M, Taylor
openaire +2 more sources
Current Opinion in Oncology, 1993
Renal cell carcinoma remains a challenge for oncologists, with only 20% of patients being cured by surgical removal of the involved kidney and a handful of patients with advanced disease being cured by surgery, immunotherapy, or both. Although advances in early detection, recognition of high-risk groups, and chemotherapy remain disappointing, advances ...
openaire +7 more sources
Renal cell carcinoma remains a challenge for oncologists, with only 20% of patients being cured by surgical removal of the involved kidney and a handful of patients with advanced disease being cured by surgery, immunotherapy, or both. Although advances in early detection, recognition of high-risk groups, and chemotherapy remain disappointing, advances ...
openaire +7 more sources
Current Opinion in Oncology, 2006
In this review we will highlight the recent novel contributions to the treatment of renal cell carcinoma in the fields of anti-angiogenesis, immunotherapeutics, and surgical management. In addition, this review will update recent advances in diagnostic and imaging modalities for renal cell carcinoma and dietary and environmental relationships to the ...
Brian I, Rini +2 more
openaire +2 more sources
In this review we will highlight the recent novel contributions to the treatment of renal cell carcinoma in the fields of anti-angiogenesis, immunotherapeutics, and surgical management. In addition, this review will update recent advances in diagnostic and imaging modalities for renal cell carcinoma and dietary and environmental relationships to the ...
Brian I, Rini +2 more
openaire +2 more sources
Current Opinion in Oncology, 1999
In addition to the known risk factors for renal cell carcinoma, hypertension, obesity, and tobacco use, a diet high in consumption of fried or sautéed meat and the frequent consumption of poultry may increase the risk for renal cell carcinoma. A diet high in consumption of fruits and vegetables appears to have a protective effect. Molecular markers, in
P A, Godley, T E, Stinchcombe
openaire +2 more sources
In addition to the known risk factors for renal cell carcinoma, hypertension, obesity, and tobacco use, a diet high in consumption of fried or sautéed meat and the frequent consumption of poultry may increase the risk for renal cell carcinoma. A diet high in consumption of fruits and vegetables appears to have a protective effect. Molecular markers, in
P A, Godley, T E, Stinchcombe
openaire +2 more sources
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
New England Journal of MedicineBACKGROUND Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial.
T. Choueiri +32 more
semanticscholar +1 more source
The Lancet
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young +7 more
openaire +2 more sources
The landscape of the management of renal cell carcinoma has evolved substantially in the last decade, leading to improved survival in localised and advanced disease. We review the epidemiology, pathology, and diagnosis of renal cell carcinoma and discuss the evidence for current management strategies from localised to metastatic disease.
Matthew, Young +7 more
openaire +2 more sources
Current Opinion in Oncology, 2007
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell +2 more
openaire +2 more sources
This review highlights recent contributions to the biology and treatment of renal cell carcinoma, the expanded use of antiangiogenic agents as well as interest in other inhibitory drug mechanisms. In addition, recent findings are reported on biomarkers which are undergoing investigation as correlative prognostic indicators of either survival or ...
W Kimryn, Rathmell +2 more
openaire +2 more sources
The Lancet, 2019
BACKGROUND A phase 2 trial showed improved progression-free survival for atezolizumab plus bevacizumab versus sunitinib in patients with metastatic renal cell carcinoma who express programmed death-ligand 1 (PD-L1). Here, we report results of IMmotion151,
B. Rini +31 more
semanticscholar +1 more source
BACKGROUND A phase 2 trial showed improved progression-free survival for atezolizumab plus bevacizumab versus sunitinib in patients with metastatic renal cell carcinoma who express programmed death-ligand 1 (PD-L1). Here, we report results of IMmotion151,
B. Rini +31 more
semanticscholar +1 more source
Southern Medical Journal, 1979
We reviewed the total experience with renal cell carcinoma at West Virginia University Hospital since its opening 15 years ago. While the conclusions are not new, our series of 89 cases reemphasizes the capriciously ubiquitous nature of the disease.
S C, Rochman, J A, Belis, S J, Kandzari
openaire +2 more sources
We reviewed the total experience with renal cell carcinoma at West Virginia University Hospital since its opening 15 years ago. While the conclusions are not new, our series of 89 cases reemphasizes the capriciously ubiquitous nature of the disease.
S C, Rochman, J A, Belis, S J, Kandzari
openaire +2 more sources